Neumora Therapeutics

Description

Develops treatments for brain diseases, advancing CNS-targeted medicines and precision approaches to understand disease biology and identify patient populations with unmet medical needs.

Related

• Crinetics Pharmaceuticals, Inc.Crinetics Pharmaceuticals develops endocrine-focused medicines, advancing programs and partnerships intended to improve treatment options…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• InsitroBuilds AI systems using automated cellular experiments and population genetics to identify causal disease targets and design therapeutics…
• Whitehead Institute for Biomedical ResearchConducts basic biomedical research to understand disease mechanisms and inform medicine, while offering programs, lectures, and events for…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…
• Recursion ($RXRX)Builds an automated AI drug discovery platform that maps disease biology from cell images and lab data to design potential medicines for…
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• Variant BioDevelops precision medicines using genomic data from people with exceptional health traits to identify genetically supported targets for…
• Generate BiomedicinesDevelops programmable protein-based medicines using generative biology, with clinical development and IND work focused on immunology and…
• Atlas VentureBuilds biotechnology companies by partnering with life science entrepreneurs to translate scientific research into medicines for patients…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Tessera TherapeuticsDevelops Gene Writing technology and non-viral delivery methods to make targeted genome alterations for therapies addressing major unmet…